Canelli Robert, Louca Joseph, Gonzalez Mauricio, Sia Michelle, Baker Maxwell B, Varghese Shama, Dienes Erin, Bilotta Federico
Department of Anesthesiology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA.
Department of Obstetrics and Gynecology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA.
J Clin Med. 2024 Aug 10;13(16):4704. doi: 10.3390/jcm13164704.
: Elevated glycemic variability (GV) has been associated with postoperative morbidity. Traditional preoperative fasting guidelines may contribute to high GV by driving the body into catabolism. Enhanced recovery after surgery (ERAS) protocols that include a preoperative carbohydrate load (PCL) reduce hospital length of stay and healthcare costs; however, it remains unclear whether PCL improves GV in surgical patients. The aim of this retrospective study was to determine the effect of a PCL on postoperative GV in diabetic and non-diabetic patients having gynecological surgery. : Retrospective data were collected on patients who had gynecological surgery before and after the rollout of an institutional ERAS protocol that included PCL ingestion. The intervention group included patients who underwent surgery in 2019 and were enrolled in the ERAS protocol and, therefore, received a PCL. The control group included patients who underwent surgery in 2016 and, thus, were not enrolled in the protocol. The primary endpoint was GV, calculated by the coefficient of variance (CV) and glycemic lability index (GLI). : A total of 63 patients in the intervention group and 45 in the control were analyzed. GV was not statistically significant between the groups for CV (19.3% vs. 18.6%, = 0.65) or GLI (0.58 vs. 0.54, = 0.86). Postoperative pain scores (4.5 vs. 5.2 = 0.23) and incentive spirometry measurements (1262 vs. 1245 = 0.87) were not significantly different. A subgroup analysis of patients with and without type 2 diabetes mellitus revealed no significant differences in GV for any of the subgroups. : This retrospective review highlights the need for additional GV research, including consensus agreement on a gold standard GV measurement. Large-scale prospective studies are needed to test the effectiveness of the PCL in reducing GV.
血糖变异性(GV)升高与术后发病率相关。传统的术前禁食指南可能会使身体进入分解代谢状态,从而导致高血糖变异性。包括术前碳水化合物负荷(PCL)的术后加速康复(ERAS)方案可缩短住院时间并降低医疗成本;然而,PCL是否能改善手术患者的血糖变异性仍不清楚。这项回顾性研究的目的是确定PCL对接受妇科手术的糖尿病和非糖尿病患者术后血糖变异性的影响。:收集了在实施包括PCL摄入的机构ERAS方案前后接受妇科手术的患者的回顾性数据。干预组包括2019年接受手术并参加ERAS方案、因此接受了PCL的患者。对照组包括2016年接受手术、因此未参加该方案的患者。主要终点是血糖变异性,通过变异系数(CV)和血糖不稳定指数(GLI)计算。:共分析了干预组的63例患者和对照组的45例患者。两组之间的CV(19.3%对18.6%,P = 0.65)或GLI(0.58对0.54,P = 0.86)的血糖变异性无统计学意义。术后疼痛评分(4.5对5.2,P = 0.23)和激励肺活量测定值(1262对1245,P = 0.87)无显著差异。对有和没有2型糖尿病的患者进行的亚组分析显示,任何亚组的血糖变异性均无显著差异。:这项回顾性综述强调了对血糖变异性进行更多研究的必要性,包括就血糖变异性测量的金标准达成共识。需要进行大规模前瞻性研究来测试PCL在降低血糖变异性方面的有效性。